How Aging Bodies Change the Risk-Benefit Calculus for Common Prescriptions
Older adults often face a shifting landscape for common medications as new research reveals that drugs effective for younger patients may pose disproportionate risks or offer limited benefits for seniors. This process typically begins with clinical studies highlighting these discrepancies, leading to revised medical guidelines and potential FDA safety alerts. Consequently, certain medications may be added to the Beers Criteria, a list of potentially inappropriate drugs for older patients, or face cautions from the U.S. Preventive Services Task Force. This dynamic regulatory and clinical review ensures that prescribing practices evolve to protect vulnerable populations, though the primary source text is truncated and does not name the specific three drugs in question.
